Fulgent Genetics EBITDA 2015-2024 | FLGT

Fulgent Genetics ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Fulgent Genetics Annual EBITDA
(Millions of US $)
2023 $-53
2022 $216
2021 $695
2020 $294
2019 $2
2018 $-3
2017 $-1
2016 $2
2015 $-4
2014 $-1
Fulgent Genetics Quarterly EBITDA
(Millions of US $)
2024-09-30 $-12
2024-06-30 $-14
2024-03-31 $-16
2023-12-31 $-26
2023-09-30 $5
2023-06-30 $-14
2023-03-31 $-18
2022-12-31 $-26
2022-09-30 $11
2022-06-30 $22
2022-03-31 $209
2021-12-31 $156
2021-09-30 $165
2021-06-30 $103
2021-03-31 $270
2020-12-31 $228
2020-09-30 $64
2020-06-30 $3
2020-03-31 $-1
2019-12-31 $0
2019-09-30 $2
2019-06-30 $1
2019-03-31 $-1
2018-12-31 $-0
2018-09-30 $-0
2018-06-30 $-0
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-1
2017-06-30 $0
2017-03-31 $1
2016-12-31 $2
2016-09-30 $-0
2016-06-30 $1
2016-03-31 $-0
2015-12-31
2015-09-30 $1
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.547B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00